AKT1 and urinary bladder cancer: In summary, we examined the expression level and the role of BHLHE41 in bladder cancer, and identified that BHLHE41 inhibited bladder cancer progression via regulation of PYCR1 stability and thus inactivating of PI3K/AKT signaling pathway.